Downregulation of LRP/LR with siRNA inhibits several cancer hallmarks in lung cancer cells
Open Access
- 13 January 2023
- journal article
- research article
- Published by Wiley in FEBS Open Bio
- Vol. 13 (2) , 323-340
Abstract
The incidence and mortality rates of cancer are growing rapidly worldwide, with lung cancer being the most commonly occurring cancer in males. Human carcinomas circumvent the inhibitory pathways induced by DNA damage and senescence through the upregulation of telomerase activity. The 37 kDa/67 kDa laminin receptor (LRP/LR) is a cell surface receptor which plays a role in several cancer hallmarks, including metastasis, angiogenesis, cell viability maintenance, apoptotic evasion, and mediating telomerase activity. We have previously shown that the knockdown of LRP/LR with an LRP‐specific siRNA significantly impedes adhesion and invasion, induces apoptosis, and inhibits telomerase activity in various cancer cell lines in vitro. Here, we investigated the effect of downregulating LRP/LR with LRP‐specific siRNA in A549 lung cancer cells. Downregulation of LRP/LR resulted in a significant decrease in cell viability, migration potential, and telomerase activity, as well as a significant increase in apoptosis. Proteomic analysis further suggested the re‐establishment of immune control over the lung cancer cells, a previously unidentified facet of LRP downregulation in cancer. Altogether, we suggest that targeting LRP/LR for downregulation may have therapeutic potential for inhibiting several cancer hallmarks.Keywords
Funding Information
- Cancer Association of South Africa
- National Research Foundation (105832)
This publication has 77 references indexed in Scilit:
- Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen depositionBMC Cancer, 2014
- Adhesion and Invasion of Breast and Oesophageal Cancer Cells Are Impeded by Anti-LRP/LR-Specific Antibody IgG1-iS18PLOS ONE, 2013
- Downregulation of the Non-Integrin Laminin Receptor Reduces Cellular Viability by Inducing Apoptosis in Lung and Cervical Cancer CellsPLOS ONE, 2013
- Anti-LRP/LR-Specific Antibody IgG1-iS18 Significantly Reduces Adhesion and Invasion of Metastatic Lung, Cervix, Colon and Prostate Cancer CellsJournal of Molecular Biology, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The ISG56/IFIT1 Gene FamilyJournal of Interferon & Cytokine Research, 2011
- Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancerOncogene, 2009
- UBE1L causes lung cancer growth suppression by targeting cyclin D1Molecular Cancer Therapeutics, 2008
- Invasion of Tumorigenic HT1080 Cells Is Impeded by Blocking or Downregulating the 37-kDa/67-kDa Laminin ReceptorJournal of Molecular Biology, 2008
- A survey of telomerase activity in human cancerEuropean Journal of Cancer, 1997